Results 111 to 120 of about 10,710,575 (236)

Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study

open access: yesBMC Medicine
Background The efficacy and safety of anti-HER2 therapy and immune checkpoint inhibitors combined with chemotherapy to treat HER2-positive advanced breast cancer that has failed standard HER2-directed therapies is unknown.
Huimin Lv   +19 more
doaj   +1 more source

Gene expression profiling predicts clinical outcome of breast cancer

open access: yesNature, 2002
L. van 't Veer   +15 more
semanticscholar   +1 more source

Landscape of gene fusions in hormone receptor-positive breast cancer reveals ADK fusions as drivers of progression and potential therapeutic targets

open access: yesCell Discovery
Gene fusions are becoming critical oncogenic drivers with potential therapeutic relevance across various cancers. However, their roles and clinical implications in breast cancer remain largely unexplored.
Yang Ou-Yang   +8 more
doaj   +1 more source

Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study

open access: yesnpj Breast Cancer
Pregnancy-associated breast cancer (PABC), diagnosed during or shortly after pregnancy, is a challenging entity with an aggressive biology and poor prognosis.
Regina Peña-Enríquez   +24 more
doaj   +1 more source

Breast cancer [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 1995
openaire   +2 more sources

Peripheral Absolute Lymphocyte Count, Breast Cancer-Specific and Overall Mortality According to Race, Ethnicity, and Breast Cancer Subtypes. [PDF]

open access: yesCancer Epidemiol Biomarkers Prev
Thompson CN   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy